Charity News from Thursday, Nov. 20, 2003The Life-saving Gift of Bone MarrowDuke University Medical Center | Since the late 1960s, tremendous strides have been made in the field of stem cell and bone marrow transplantation. Today, these procedures routinely help treat many people suffering from life-threatening diseases such as leukemia and lymphoma. Understanding How Lymph Nodes Respond to Infection May Redefine How Immune System Functions Duke University Medical Center | Duke University Medical Center researchers may have solved the mystery of why lymph nodes swell when the body fights infection. Their findings may redefine how the immune system functions, they said. Experimental Drugs Show Promise in Halting Brain Tumors Duke University Medical Center | Researchers at the Duke Comprehensive Cancer Center have shown that four new and experimental drugs can strongly inhibit the growth of deadly brain tumors in animals, and they expect these promising results to hold true in humans, as well. Emory Scientists Find Marker for Long-Term Immunity Emory University | Scientists at the Emory Vaccine Center and The Scripps Research Institute have found a way to identify which of the T cells generated after a viral infection can persist and confer protective immunity. 14th International Symposium on ALS/MND Milan Meeting Highlights Muscular Dystrophy Association | Progress in ALS research was the topic at the 11th annual meeting of the International Alliance of ALS/MND (Motor Neurone Disease) Associations and the 14th International Symposium on ALS/MND, held in Milan, Italy, Nov. 13 through 19. Hassle-free stroke prevention offered by new drug, says Stanford researcher Stanford University School of Medicine | People who take a commonly prescribed yet problematic drug called Coumadin to prevent stroke or blood clots may soon have a hassle-free alternative, according to research at Stanford University School of Medicine. Investigational drug brings new hope to kidney cancer patients The University of Chicago Medical Center | Preliminary results from a phase II trial of an investigational drug known as BAY 43-9006 demonstrate a significant short-term benefit for patients with advanced renal cell cancer, researchers reported at the AACR meeting in Boston. Sinus Infection Expert and Surgeon Alexander G. Chiu, MD, Joins the University of Pennsylvania School of Medicine University of Pennsylvania School of Medicine | Surgeon Alexander G. Chiu, MD, has joined the Department of Otorhinolaryngology – Head and Neck Surgery at the University of Pennsylvania School of Medicine as Assistant Professor. Researchers to Study Mental Health Effects of 9/11 Attacks Washington University School of Medicine in St. Louis | Researchers at Washington University School of Medicine in St. Louis have received a $2.5 million grant to lead a study of the persistent mental health impact of the Sept. 11th terrorist attacks on people who were in the World Trade Center towers. New Chair Chosen for International Panel of Experts American Institute for Cancer Research | The American Institute for Cancer Research (AICR) announced today that Dr. Michael Marmot has been appointed to chair a panel of the world's leading cancer and nutrition experts. Research Trial for Multiple Sclerosis at Mayo Clinic Mayo Clinic | Mayo Clinic in Scottsdale seeks men and women between the ages 18 and 50 with early, relapsing-remitting Multiple Sclerosis (MS) to participate in a clinical research study to compare investigational drug vs. standard treatment.
|
|
